<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04267510</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0085</org_study_id>
    <nct_id>NCT04267510</nct_id>
  </id_info>
  <brief_title>Clinical and Molecular Aspects of Early Osteoarthritis</brief_title>
  <official_title>Clinical and Molecular Aspects of Early Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The etiology of osteoarthritis is varied, ranging from multifactorial, environmental to
      monogenic. In individuals in whom osteoarthritis appears earlier than in the general
      population, it is called early osteoarthritis. To our knowledge, there are no large-scale
      genetic studies on people with early osteoarthritis. The investigators therefore sought to
      study the causes of monogenic osteoarthritis in people suffering from early non-syndromic
      osteoarthritis.

      Material and method From 2013 to 2019, experts in constitutional bone disease sent patients
      with non-syndromic early osteoarthritis for genetic analysis to our center of competence for
      constitutional bone diseases. The sequencing of a panel of genes was carried out by NGS.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2013</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>identification of genetic mutation</measure>
    <time_frame>1 day</time_frame>
    <description>sequencing out by NGS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of genetic mutation</measure>
    <time_frame>1 day</time_frame>
    <description>sequencing out by NGS</description>
  </primary_outcome>
  <enrollment type="Actual">65</enrollment>
  <condition>Early Osteoarthritis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with early osteoarthritis who have undergone genetic sequencing
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Patients with early osteoarthritis who have undergone genetic sequencing

        Exclusion Criteria:

        - Patients refusing to participate in research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David GENEVIEVE</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Medical Genetics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UH Montpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 7, 2020</study_first_submitted>
  <study_first_submitted_qc>February 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2020</study_first_posted>
  <last_update_submitted>February 11, 2020</last_update_submitted>
  <last_update_submitted_qc>February 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>genetic sequencing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

